AI assistant
ECHOIQ LIMITED — Capital/Financing Update 2022
Aug 11, 2022
64833_rns_2022-08-11_6fc03939-60f9-4ac0-b3ef-701d8e06bc75.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [596 x 112] intentionally omitted <==
ASX: EIQ RELEASE
12 AUGUST, 2022
S708A CLEANSING NOTICE
Sydney: AI & Medical Technology company Echo IQ (the Company) (ASX:EIQ) issued 312,500 fully paid ordinary shares (Shares) on 10 August 2022 pursuant to the exercise of unlisted options.
The Shares are part of a class of securities quoted on the Australian Securities Exchange Limited (ASX).
The Company gives this notice pursuant to Section 708A(5)(e) of the Corporations Act 2001. The Shares were issued without disclosure to the investors under Part 6D.2, in reliance on Section 708A(5) of the Corporations Act 2001. The Company, as at the date of this notice, has complied with:
the provisions of Chapter 2M of the Corporations Act 2001; and Section 674 of the Corporations Act 2001.
There is no excluded information as at the date of this notice, for the purposes of Sections 708A(7) and (8) of the Corporations Act 2001.
-ENDS-
Authorised for release by the Board of Directors of Echo IQ Limited.
Media enquiries:
Philip Woolff, Chief Operating Officer [email protected] / +61 (0)490 030 620 / [email protected]
Investor enquiries:
Andrew Grover, Executive Chair [email protected] / [email protected]
ABOUT ECHO IQ
Echo IQ uses AI-driven technology and proprietary software to improve decision making in Cardiology, Health Insurance and Defence. The company is based in Sydney, Australia.
==> picture [596 x 54] intentionally omitted <==